APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adult and Adolescent Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Adult and Adolescent Vaccines Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchAdult and Adolescent Vaccines Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Adult and Adolescent Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Adult and Adolescent Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adult and Adolescent Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Adult and Adolescent Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adult and Adolescent Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Adult and Adolescent Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Adult and Adolescent Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Adult and Adolescent Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Adult and Adolescent Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Adult and Adolescent Vaccines include Novartis, Merck, Pfizer, GlaxoSmithKline and Sanofi Aventis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Adult and Adolescent Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Adult and Adolescent Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Adult and Adolescent Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adult and Adolescent Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adult and Adolescent Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Adult and Adolescent Vaccines sales, projected growth trends, production technology, application and end-user industry.

Adult and Adolescent Vaccines Segment by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

Sanofi Aventis

Adult and Adolescent Vaccines Segment by Type

Seasonal Vaccines

Travel Vaccines

Adult and Adolescent Vaccines Segment by Application

Adult

Adolescent

Adult and Adolescent Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Adolescent Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adult and Adolescent Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Adolescent Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Adult and Adolescent Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Adult and Adolescent Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adult and Adolescent Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Adult and Adolescent Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Seasonal Vaccines Major Manufacturers Table 3. Travel Vaccines Major Manufacturers Table 4. Global Adult and Adolescent Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Adolescent Major Manufacturers Table 7. Adult and Adolescent Vaccines Industry Trends Table 8. Adult and Adolescent Vaccines Industry Drivers Table 9. Adult and Adolescent Vaccines Industry Opportunities and Challenges Table 10. Adult and Adolescent Vaccines Industry Restraints Table 11. Global Adult and Adolescent Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Adult and Adolescent Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Adult and Adolescent Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Adult and Adolescent Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Adult and Adolescent Vaccines Sales by Region (2021-2026) & (k units) Table 18. Global Adult and Adolescent Vaccines Sales by Region (2027-2032) & (k units) Table 19. Global Adult and Adolescent Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Adult and Adolescent Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Adult and Adolescent Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Adult and Adolescent Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Adult and Adolescent Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Adult and Adolescent Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Adult and Adolescent Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Adult and Adolescent Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Adult and Adolescent Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Adult and Adolescent Vaccines Manufacturers, Product Type & Application Table 29. Global Adult and Adolescent Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Adult and Adolescent Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Adult and Adolescent Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Adult and Adolescent Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 39. Global Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 40. Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Adult and Adolescent Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Adult and Adolescent Vaccines Price by Type (2021-2026) & (US$/unit) Table 43. Global Adult and Adolescent Vaccines Price by Type (2027-2032) & (US$/unit) Table 44. Global Adult and Adolescent Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Adult and Adolescent Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 51. Global Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 52. Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Adult and Adolescent Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Adult and Adolescent Vaccines Price by Application (2021-2026) & (US$/unit) Table 55. Global Adult and Adolescent Vaccines Price by Application (2027-2032) & (US$/unit) Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Novartis Adult and Adolescent Vaccines Product Portfolio Table 60. Novartis Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Merck Adult and Adolescent Vaccines Product Portfolio Table 65. Merck Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Pfizer Adult and Adolescent Vaccines Product Portfolio Table 70. Pfizer Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Sanofi Aventis Company Information Table 77. Sanofi Aventis Business Overview Table 78. Sanofi Aventis Adult and Adolescent Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio Table 80. Sanofi Aventis Recent Development Table 81. North America Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 84. North America Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 85. North America Adult and Adolescent Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Adult and Adolescent Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 90. North America Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 91. North America Adult and Adolescent Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Adult and Adolescent Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Adult and Adolescent Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 98. North America Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 99. North America Adult and Adolescent Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Adult and Adolescent Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 102. Canada Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 103. Mexico Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 104. Europe Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 107. Europe Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 108. Europe Adult and Adolescent Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Adult and Adolescent Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 113. Europe Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 114. Europe Adult and Adolescent Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Adult and Adolescent Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Adult and Adolescent Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 121. Europe Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 122. Europe Adult and Adolescent Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Adult and Adolescent Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 125. France Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 126. U.K. Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 127. Italy Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 128. Russia Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 129. Spain Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 132. Sweden Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 133. Poland Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 134. China Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 135. China Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 136. China Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 137. China Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 138. China Adult and Adolescent Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Adult and Adolescent Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 141. China Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 142. China Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 143. China Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 144. China Adult and Adolescent Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Adult and Adolescent Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 149. Asia Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 150. Asia Adult and Adolescent Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Adult and Adolescent Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 155. Asia Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 156. Asia Adult and Adolescent Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Adult and Adolescent Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Adult and Adolescent Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 163. Asia Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 164. Asia Adult and Adolescent Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Adult and Adolescent Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 167. South Korea Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 168. India Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 169. Australia Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Adult and Adolescent Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Adult and Adolescent Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Adult and Adolescent Vaccines Sales by Type (2021-2026) & (k units) Table 175. SAMEA Adult and Adolescent Vaccines Sales by Type (2027-2032) & (k units) Table 176. SAMEA Adult and Adolescent Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Adult and Adolescent Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Adult and Adolescent Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Adult and Adolescent Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Adult and Adolescent Vaccines Sales by Application (2021-2026) & (k units) Table 181. SAMEA Adult and Adolescent Vaccines Sales by Application (2027-2032) & (k units) Table 182. SAMEA Adult and Adolescent Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Adult and Adolescent Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Adult and Adolescent Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Adult and Adolescent Vaccines Sales by Country (2021-2026) & (k units) Table 189. SAMEA Adult and Adolescent Vaccines Sales by Country (2027-2032) & (k units) Table 190. SAMEA Adult and Adolescent Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Adult and Adolescent Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 193. Argentina Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 194. Chile Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 195. Colombia Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 196. Peru Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Israel Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 199. UAE Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Turkey Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Iran Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Egypt Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Adult and Adolescent Vaccines Distributors List Table 206. Adult and Adolescent Vaccines Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Adult and Adolescent Vaccines Image Figure 2. Global Adult and Adolescent Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adult and Adolescent Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Seasonal Vaccines Image Figure 5. Travel Vaccines Image Figure 6. Global Adult and Adolescent Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Adult and Adolescent Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Adolescent Image Figure 10. Global Adult and Adolescent Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Adult and Adolescent Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Adult and Adolescent Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Adult and Adolescent Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Adult and Adolescent Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Adult and Adolescent Vaccines Sales (2021-2032) & (k units) Figure 16. Global Adult and Adolescent Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Adult and Adolescent Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Adult and Adolescent Vaccines Sales YoY (2021-2032) & (k units) Figure 19. Europe Adult and Adolescent Vaccines Sales YoY (2021-2032) & (k units) Figure 20. China Adult and Adolescent Vaccines Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Adult and Adolescent Vaccines Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Adult and Adolescent Vaccines Sales YoY (2021-2032) & (k units) Figure 23. Global Adult and Adolescent Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Adult and Adolescent Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Adult and Adolescent Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Adult and Adolescent Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global Adult and Adolescent Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Adult and Adolescent Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global Adult and Adolescent Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Adult and Adolescent Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global Adult and Adolescent Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Adult and Adolescent Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America Adult and Adolescent Vaccines Revenue Share by Type (2021-2032) Figure 39. North America Adult and Adolescent Vaccines Sales Share by Type (2021-2032) Figure 40. North America Adult and Adolescent Vaccines Revenue Share by Application (2021-2032) Figure 41. North America Adult and Adolescent Vaccines Sales Share by Application (2021-2032) Figure 42. North America Adult and Adolescent Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Adult and Adolescent Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Adult and Adolescent Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe Adult and Adolescent Vaccines Sales Share by Type (2021-2032) Figure 46. Europe Adult and Adolescent Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe Adult and Adolescent Vaccines Sales Share by Application (2021-2032) Figure 48. Europe Adult and Adolescent Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Adult and Adolescent Vaccines Sales Share by Country (2021-2032) Figure 50. China Adult and Adolescent Vaccines Revenue Share by Type (2021-2032) Figure 51. China Adult and Adolescent Vaccines Sales Share by Type (2021-2032) Figure 52. China Adult and Adolescent Vaccines Revenue Share by Application (2021-2032) Figure 53. China Adult and Adolescent Vaccines Sales Share by Application (2021-2032) Figure 54. Asia Adult and Adolescent Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia Adult and Adolescent Vaccines Sales Share by Type (2021-2032) Figure 56. Asia Adult and Adolescent Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia Adult and Adolescent Vaccines Sales Share by Application (2021-2032) Figure 58. Asia Adult and Adolescent Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Adult and Adolescent Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Adult and Adolescent Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA Adult and Adolescent Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA Adult and Adolescent Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA Adult and Adolescent Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA Adult and Adolescent Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Adult and Adolescent Vaccines Sales Share by Country (2021-2032) Figure 66. Adult and Adolescent Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Adult and Adolescent Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Seasonal Vaccines
  • Travel Vaccines
Applications
  • Adult
  • Adolescent
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Sanofi Aventis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Adult and Adolescent Vaccines Market by Type
  3. 1.2.1 Global Adult and Adolescent Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Seasonal Vaccines
  5. 1.2.3 Travel Vaccines
  6. 1.3 Adult and Adolescent Vaccines Market by Application
  7. 1.3.1 Global Adult and Adolescent Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Adolescent
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Adult and Adolescent Vaccines Market Dynamics
  1. 2.1 Adult and Adolescent Vaccines Industry Trends
  2. 2.2 Adult and Adolescent Vaccines Industry Drivers
  3. 2.3 Adult and Adolescent Vaccines Industry Opportunities and Challenges
  4. 2.4 Adult and Adolescent Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Adult and Adolescent Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Adult and Adolescent Vaccines Revenue by Region
  3. 3.2.1 Global Adult and Adolescent Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Adult and Adolescent Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Adult and Adolescent Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Adult and Adolescent Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Adult and Adolescent Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Adult and Adolescent Vaccines Sales by Region
  9. 3.4.1 Global Adult and Adolescent Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Adult and Adolescent Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Adult and Adolescent Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Adult and Adolescent Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Adult and Adolescent Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Adult and Adolescent Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Adult and Adolescent Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Adult and Adolescent Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Adult and Adolescent Vaccines Sales by Manufacturers
  6. 4.2.1 Global Adult and Adolescent Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Adult and Adolescent Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Adult and Adolescent Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Adult and Adolescent Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Adult and Adolescent Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Adult and Adolescent Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Adult and Adolescent Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Adult and Adolescent Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Adult and Adolescent Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Adult and Adolescent Vaccines Tier 1, Tier 2, and Tier 3
5 Adult and Adolescent Vaccines Market by Type
  1. 5.1 Global Adult and Adolescent Vaccines Revenue by Type
  2. 5.1.1 Global Adult and Adolescent Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Adult and Adolescent Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Adult and Adolescent Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Adult and Adolescent Vaccines Sales by Type
  6. 5.2.1 Global Adult and Adolescent Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Adult and Adolescent Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Adult and Adolescent Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Adult and Adolescent Vaccines Price by Type
6 Adult and Adolescent Vaccines Market by Application
  1. 6.1 Global Adult and Adolescent Vaccines Revenue by Application
  2. 6.1.1 Global Adult and Adolescent Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Adult and Adolescent Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Adult and Adolescent Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Adult and Adolescent Vaccines Sales by Application
  6. 6.2.1 Global Adult and Adolescent Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Adult and Adolescent Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Adult and Adolescent Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Adult and Adolescent Vaccines Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Adult and Adolescent Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Adult and Adolescent Vaccines Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Adult and Adolescent Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Adult and Adolescent Vaccines Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Adult and Adolescent Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Adult and Adolescent Vaccines Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Adult and Adolescent Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Adult and Adolescent Vaccines Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Sanofi Aventis
  26. 7.5.1 Sanofi Aventis Company Information
  27. 7.5.2 Sanofi Aventis Business Overview
  28. 7.5.3 Sanofi Aventis Adult and Adolescent Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Aventis Adult and Adolescent Vaccines Product Portfolio
  30. 7.5.5 Sanofi Aventis Recent Developments
8 North America
  1. 8.1 North America Adult and Adolescent Vaccines Market Size by Type
  2. 8.1.1 North America Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Adult and Adolescent Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Adult and Adolescent Vaccines Price by Type (2021-2032)
  5. 8.2 North America Adult and Adolescent Vaccines Market Size by Application
  6. 8.2.1 North America Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Adult and Adolescent Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Adult and Adolescent Vaccines Price by Application (2021-2032)
  9. 8.3 North America Adult and Adolescent Vaccines Market Size by Country
  10. 8.3.1 North America Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Adult and Adolescent Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Adult and Adolescent Vaccines Market Size by Type
  2. 9.1.1 Europe Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Adult and Adolescent Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Adult and Adolescent Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Adult and Adolescent Vaccines Market Size by Application
  6. 9.2.1 Europe Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Adult and Adolescent Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Adult and Adolescent Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Adult and Adolescent Vaccines Market Size by Country
  10. 9.3.1 Europe Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Adult and Adolescent Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Adult and Adolescent Vaccines Market Size by Type
  2. 10.1.1 China Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Adult and Adolescent Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Adult and Adolescent Vaccines Price by Type (2021-2032)
  5. 10.2 China Adult and Adolescent Vaccines Market Size by Application
  6. 10.2.1 China Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Adult and Adolescent Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Adult and Adolescent Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Adult and Adolescent Vaccines Market Size by Type
  2. 11.1.1 Asia Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Adult and Adolescent Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Adult and Adolescent Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Adult and Adolescent Vaccines Market Size by Application
  6. 11.2.1 Asia Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Adult and Adolescent Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Adult and Adolescent Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Adult and Adolescent Vaccines Market Size by Country
  10. 11.3.1 Asia Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Adult and Adolescent Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Adult and Adolescent Vaccines Market Size by Type
  2. 12.1.1 SAMEA Adult and Adolescent Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Adult and Adolescent Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Adult and Adolescent Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Adult and Adolescent Vaccines Market Size by Application
  6. 12.2.1 SAMEA Adult and Adolescent Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Adult and Adolescent Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Adult and Adolescent Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Adult and Adolescent Vaccines Market Size by Country
  10. 12.3.1 SAMEA Adult and Adolescent Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Adult and Adolescent Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Adult and Adolescent Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Adult and Adolescent Vaccines Value Chain Analysis
  2. 13.1.1 Adult and Adolescent Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Adult and Adolescent Vaccines Production Mode & Process
  6. 13.2 Adult and Adolescent Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Adult and Adolescent Vaccines Distributors
  9. 13.2.3 Adult and Adolescent Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst